# Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy

> **NCT05472792** · PHASE2 · RECRUITING · sponsor: **UNC Lineberger Comprehensive Cancer Center** · enrollment: 90 (estimated)

## Conditions studied

- Breast Cancer
- Quality of Life

## Interventions

- **RADIATION:** Accelerated Partial Breast Irradiation (APBI)
- **DRUG:** tamoxifen, anastrozole, exemestane, letrozole, fulvestrant, toremifene

## Key facts

- **NCT ID:** NCT05472792
- **Lead sponsor:** UNC Lineberger Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-05-17
- **Primary completion:** 2027-04-15
- **Final completion:** 2032-04-15
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05472792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05472792, "Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05472792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*